Acute Myocardial Infarction Due to Eltrombopag Therapy in a Patient with Immune Thrombocytopenic Purpura

Journal Title: Turkish Journal of Hematology - Year 2017, Vol 34, Issue 1

Abstract

Acute Myocardial Infarction Due to Eltrombopag Therapy in a Patient with Immune Thrombocytopenic Purpura

Authors and Affiliations

Sena Sert, Hasan Özdil, Murat Sünbül

Keywords

Related Articles

About Pyrimidine 5’-Nucleotidase Deficiency

 To the Editor, Agapidou et al.’s case of pyrimidine 5’-nucleotidase defi ciency and heterozygous α-thalassemia was an interesting co-existence [1]. Did the authors have the chance to study the offspring for these...

Tendency of K562 Chronic Myeloid Leukemia Cells Towards Cell Reprogramming

Objective: Cancer cell reprogramming is a potential tool to study cancer progression, disease pathology, and drug sensitivity. Prior to performing cancer reprogramming studies, it is important to evaluate the stemness pr...

Download PDF file
  • EP ID EP224114
  • DOI 10.4274/tjh.2016.0169
  • Views 93
  • Downloads 0

How To Cite

Sena Sert, Hasan Özdil, Murat Sünbül (2017). Acute Myocardial Infarction Due to Eltrombopag Therapy in a Patient with Immune Thrombocytopenic Purpura. Turkish Journal of Hematology, 34(1), 107-108. https://europub.co.uk/articles/-A-224114